Mahinay, Eunna Pearl G.
HRN: 23-61-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
CEFUROXIME 750MG (VIAL)
08/26/2023
09/02/2023
IV
200mg
Q8
PCAP
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes